CEO Gang Lai Discloses 13.58% Beneficial Ownership in Universe Pharmaceuticals
UPC sits 35% above its 52-week low of $2 on light trading volume (0.3× avg).
Summary
CEO Gang Lai has formally disclosed a 13.58% beneficial ownership stake in Universe Pharmaceuticals INC, consolidating significant control following a recent equity grant.
Key Events · Ownership and Investor Activity · UPC
-
CEO's Significant Stake
CEO Gang Lai now beneficially owns 87,967 shares, representing 13.58% of the company's outstanding Class A ordinary shares.
-
Acquisition Method
The shares were acquired via an equity grant for past services rendered, not through a cash purchase.
-
Consolidated Control
This substantial ownership percentage gives the CEO significant control over the company's operations and governance.
-
Follows Prior Disclosure
This filing provides precise details on the beneficial ownership resulting from an equity grant to the CEO that was previously disclosed on May 14, 2026.
Analysis · UPC · Life Sciences
This Schedule 13D filing formalizes CEO Gang Lai's significant beneficial ownership stake of 13.58% in Universe Pharmaceuticals INC. While the shares were acquired through an equity grant for past services rendered, previously disclosed, this filing provides precise details on the CEO's total holdings, including direct ownership and shares held through Sununion Holding Group Limited. This substantial ownership percentage consolidates control with the CEO, aligning his interests with the company's long-term performance.
At the time of this filing, UPC was trading at $2.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $2.00 to $11.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.